Card Id
|
Type Of Strain
|
Strain Name
|
Internal Code
|
Gene Symbol
|
Gene Name
|
Disease
|
Stock Type
|
Submitter
|
Developer
|
imsr
|
|
Targeted mutant.
|
129-Ttrtm1
|
Mshum1,M
|
Ttr
|
transthyretin
|
Development Immunology Metabolism Neurobiology
|
|
Unknown Unknown
|
Shuichiro Maeda Dr. EJ R(The First Department of Biochemistry Yamanashi Medical University) Shuichiro Maeda Dr. EJ R(Columbia University)
|
Released publicly
|
|
Targeted mutant.
|
129.Cg-Atp1a2tm1Kwk
|
tmCKwk
|
Atp1a2
|
ATPase, Na+/K+ transporting, alpha 2 polypeptide
|
Anatomy Dermatology Metabolism Neurobiology Physiology
|
|
KAWAKAMI KIYOSHI
|
Kiyoshi Kawakami(Jichi Medical University)
|
|
|
Targeted mutant.
|
129.Cg-Atp1a2tm2Kwk
|
tmNKwk
|
Atp1a2
|
ATPase, Na+/K+ transporting, alpha 2 polypeptide
|
Anatomy Dermatology Metabolism Neurobiology Physiology
|
|
KAWAKAMI KIYOSHI
|
Kiyoshi Kawakami(Jichi Medical University)
|
|
|
Targeted mutant.
|
129/Sv.129S4(ICR)-Parp1tm1Hsmm/Hsmm
|
129/Sv.129S4(ICR)-Parp1tm1Hsmm/Hsmm
|
Parp1
|
Poly (ADP-ribose) polymerase family, member 1
|
Immunology Metabolism Neurobiology Physiology cancer
|
|
Unknown Unknown
|
Hiroshi Suzuki, Mitsuko Masutani(Chugai Pharmaceutical Co. Ltd., National Cancer Center Research Institute)
|
|
|
Gene trap.
|
Abhd2
|
Abhd2
|
Abhd2
|
abhydrolase domain containing 2
|
Genetics Hematology Laboratory-animal Science Metabolism
|
|
Ken-ichi YAMAMURA
|
Yamamura Kenichi(Center for Animal Resources and Development, Kumamoto University)
|
|
|
Targeted mutant.
|
B6-Prss8tm1
|
floxed PRSS8 homo
|
Prss8
|
protease, serine, 8 (prostasin)
|
Metabolism
|
|
- -
|
|
|
|
Targeted mutant.
|
B6-Rpt3tm1
|
floxed Rpt3
|
Psmc4
|
proteasome (prosome, macropain) 26S subunit, ATPase, 4
|
Aging Behavior Cell biology Dentistry Dermatology Development Diabetes Digestive Disorders Endocrine Disorders Genetics Hematology Immunology Laboratory-animal Science Metabolism Molecular biology Neurobiology Obesity Ophthalomology Osteosis Otorhinology Reproduction Respiratory System Urology cancer infectious peromelia
|
|
Takahashi Ryosuke
|
Yoshitaka Tashiro , Ryousuke Takahashi(Department of Neurology kyoto University Graduate School of Medicine)
|
|
|
Transgenic.
|
B6-Tg(Fabp2-PLIN)
|
perilipin transgenic B6-Tg(Fabp2-PLIN)
|
PLIN
|
Perilipin(Human)
|
Metabolism Physiology
|
|
Unknown Unknown
|
Mikiko Endo(Department of MedicineII, Hokkaido University Graduate School of Medicin)
|
Released publicly
|
|
Transgenic.
|
B6-Tg(Pax7-YFP)
|
Pax7-YFP
|
-
|
Pax7
|
Anatomy Development Metabolism Neurobiology Physiology
|
|
Ono Yusuke
|
(UNITECH)
|
|
|
Targeted mutant.
|
B6.129(ICR)-Parp1tm1Hsmm/Hsmm
|
B6.129(ICR)-Parp1tm1Hsmm/Hsmm
|
Parp1
|
Poly (ADP-ribose) polymerase family, member 1
|
Immunology Metabolism Neurobiology Physiology cancer
|
|
Unknown Unknown
|
Hiroshi Suzuki, Mitsuko Masutani(Chugai Pharmacetical Co. Ltd., National Cancer Center Reasearch Institute)
|
|
|
Targeted mutant.
|
B6.129-Acss1tm1
|
AceCS2 -/-
|
Acss1
|
acyl-CoA synthetase short-chain family member 1
|
Metabolism
|
|
- -
|
UT South Western(Masashi Yanagisawa)
|
|
|
Targeted mutant.
|
B6.129-Atp1a2tm2Kwk
|
BL6N
|
Atp1a2
|
ATPase, Na+/K+ transporting, alpha 2 polypeptide
|
Anatomy Dermatology Metabolism Neurobiology Physiology
|
|
KAWAKAMI KIYOSHI
|
Kiyoshi Kawakami(Jichi Medical University)
|
|
|
Targeted mutant.
|
B6.129-Cckartm1
|
C57BL/6-Cckartm1
|
Cckar
|
Cholecystokinin A receptor
|
Metabolism Neurobiology Physiology cancer
|
|
Okamura Takeshi
|
Soich Takiguchi(National Kyushu Cancer Center)
|
|
|
Targeted mutant.
|
B6.129-Chrm1tm1
|
1NJ B6.129-Chrm1tm1
|
Chrm1
|
cholinergic receptor, muscarinic 1, CNS
|
Anatomy Dermatology Development Immunology Metabolism Neurobiology Physiology cancer
|
|
Unknown Unknown
|
MATSUI Minoru(Graduate Sch. Pharm, Sci., Univ.Tokyo)
|
|
|
Targeted mutant.
|
B6.129-Chrm2tm1
|
2NJ B6.129-Chrm2tm1
|
Chrm2
|
cholinergic receptor, muscarinic 2, cardiac
|
Anatomy Dermatology Development Immunology Metabolism Neurobiology Physiology cancer
|
|
Unknown Unknown
|
MATSUI Minoru(Graduate Sch. Pharm. Sci., Univ. Tokyo)
|
Released publicly
|
|
Targeted mutant.
|
B6.129-Chrm3tm1
|
3NJ B6.129-Chrm3tm1
|
Chrm3
|
cholinergic receptor, muscarinic 3, cardia
|
Anatomy Dermatology Development Immunology Metabolism Neurobiology Physiology cancer
|
|
Unknown Unknown
|
MATSUI Minoru(Graduate Sch. Pharm. Sci., Univ. Tokyo)
|
Released publicly
|
|
Targeted mutant.
|
B6.129-Chrm4tm1
|
4NJ B6.129-Chrm4tm1
|
Chm4
|
cholinergic receptor, muscarinic 4
|
Anatomy Dermatology Development Immunology Metabolism Neurobiology Physiology cancer
|
|
Unknown Unknown
|
MATSUI Minoru(Graduate Sch.Pharm. Sci., Univ. Tokyo)
|
Released publicly
|
|
Targeted mutant.
|
B6.129-Chrm5tm1
|
5NJ B6.129-Chrm5tm1
|
Chrm5
|
cholinergic receptor, muscarinic 5
|
Anatomy Dermatology Development Immunology Metabolism Neurobiology Physiology cancer
|
|
Unknown Unknown
|
MATSUI Minoru(東京大学薬学部)
|
Released publicly
|
|
Targeted mutant.
|
B6.129-Cthtm1
|
Cth-Knockout
|
Cth
|
cystathionase (cystathionine gamma-lyase)
|
Development Metabolism Physiology
|
|
ISHII ISAO
|
Isao Ishii(Showa Pharmaceutical University)
|
|
|
Targeted mutant.
|
B6.129-Edg3tm1Jch
|
SIP3-Knockout
|
Edg3
|
endothelial differentiation, sphingolipid G-protein-coupled receptor,3
|
Development Immunology Metabolism Neurobiology Physiology
|
|
ISHII ISAO
|
Isao Ishii(Showa Pharmaceutical University) Dr. Jerold Chun(The Scripps Research Institute)
|
|
|
Targeted mutant.
|
B6.129-Msr1tm1Csk
|
SR-A KO B6.129-Msr1tm1Csk
|
Msr1
|
macrophage Scavenger receptor 1
|
Anatomy Immunology Metabolism
|
|
Unknown Unknown
|
(Chugai Pharmacentical. Co, Ltd.)
|
Released publicly
|
|
Targeted mutant.
|
B6.129-Neu3tm1Myg
|
C57BL/6-Neu3tm1Myg
|
Neu3
|
neuraminidase3
|
Immunology Metabolism Neurobiology Physiology cancer
|
|
Yamaguchi Kazunori
|
Taeko Miyagi(Miyagi Cancer Center Research Institute)
|
|
|
Targeted mutant.
|
B6.129-Pkmtm1Ntan
|
PkmM1
|
Pkm
|
pyruvate kinase, muscle
|
Development Immunology Metabolism Neurobiology Physiology cancer
|
|
Tanuma Nobuhiro
|
Nobuhiro Tanuma(Miyagi Cancer Center Research Institute)
|
|
|
Targeted mutant.
|
B6.129-S1pr2tm1Jch
|
SIP2-Knockout
|
S1pr2 (Synonym: Edg5)
|
Endothelial differentiation, sphingolipid G-protein-coupled receptor,5
|
Dermatology Development Immunology Metabolism Neurobiology Physiology
|
|
ISHII ISAO
|
Isao Ishii(Showa Pharmaceutical University) Dr. Jerold Chun(The Scripps Research Institute)
|
|
|
Targeted mutant.
|
B6.129P2-Olr1tm1Saw
|
B6-Lox-1 KO B6.129P2-Olr1tm1Saw
|
Orl1(Chr6, synonym:Lox-1)
|
lectin-like oxidized low density lipoprotein receptor-1
|
Metabolism Physiology
|
|
Unknown Unknown
|
National Cardiovascular Center(Tatsuya Sawamura)
|
|
|
Targeted mutant.
|
B6.129S7-Ttpatm1Csk
|
B6-α-Ttp KO B6.129S7-Ttpatm1Csk
|
Ttpa
|
tocopherol(alpha) transfer protein
|
Development Metabolism Neurobiology Physiology
|
|
Unknown Unknown
|
Jishage Kou-ichi(Chugai Pharmaceutical. co, Ltd.)
|
Released publicly
|
|
Transgenic.
|
B6.BDF1-Tg(CAG-Cat-vIL10)Miya
|
CAG-CAT-vIL10
|
viral interleukin 10
|
vIL10
|
Immunology Metabolism
|
|
Miyazaki Jun-ichi
|
Jun-ichi Miyazaki(Osaka University Graduate School of Medicine)
|
|
|
Spontaneous/Chemical induced mutant.
|
B6.Cg(ICR)-TpoR479C-Ham
|
TpoR479C-Ham
|
Tpo
|
thyroid peroxidase
|
Metabolism
|
|
Kato Hideki
|
Hideki Katoh(Hamamatsu University School of Medicine)
|
|
|
Targeted mutant.
|
B6.Cg-Atpif1tm1
|
Atpif1 KO
|
Atpif1
|
ATPase inhibitory factor 1
|
Metabolism Unknown cancer
|
|
Masasuke Yoshida
|
Yoshida Masasuke(Department of Molecular Bioscience, Kyoto Sangyo University)
|
|
|
Targeted mutant.
|
B6;129(ICR)-Parp1tm1Hsmm Tg(GPT-delta)/Hsmm
|
B6;129(ICR)-Parp1tm1Hsmm TgN(GPT-delta)/Hsmm
|
Parp1 Parp1
|
Poly (ADP-ribose) polymerase family, member 1 Poly (ADP-ribose) polymerase family, member 1
|
Immunology Metabolism Neurobiology Physiology cancer
|
|
Unknown Unknown
|
Hiroshi Suzuki, Mitsuko Masutani(Chugai Pharmaceutical Co. Ltd., National Cancer Center Research Institute)
|
|
|
Targeted mutant.
|
B6;129-Cd51tm1
|
AIM-/-BL B6;129-Cd51tm1
|
Cd51(Synonym:Aim)
|
CD5 antigen-like
|
Immunology Metabolism
|
|
Miyazaki Toru
|
Toru Miyazaki(University of Texas Southwestern Medical Center)
|
Released publicly
|
|
Targeted mutant.
|
B6;129-Chrm1tm1 Chrm2tm1 Chrm4tm1
|
M1M2M4KO
|
Chrm1 Chrm2 Chrm4
|
cholinergic receptor, muscarinic 1, CNS cholinergic receptor, muscarinic 2 cholinergic receptor, muscarinic 4
|
Anatomy Dermatology Development Immunology Metabolism Neurobiology Physiology cancer
|
|
Unknown Unknown
|
MATSUI Minoru(Graduate Sch. Pharm. Sci., Univ. Tokyo)
|
|
|
Targeted mutant.
|
B6;129-Chrm1tm1 Chrm3tm1 Chrm5tm1
|
M1M3M5KO
|
Chrm1 Chrm3 Chrm5
|
cholinergic receptor, muscarinic 1, CNS cholinergic receptor, muscarinic 3, cardiac cholinergic receptor, muscarinic 5
|
Anatomy Dermatology Development Immunology Metabolism Neurobiology Physiology cancer
|
|
Unknown Unknown
|
MATSUI, Minoru(Graduate Sch. Pharm. Sci., Univ. Tokyo)
|
|
|
Targeted mutant.
|
B6;129-Chrm1tm1 Chrm3tm1
|
M1M3KO
|
Chrm1 Chrm3
|
cholinergic receptor, muscarinic 1, CNS cholinergic receptor, muscarinic 3, cardiac
|
Anatomy Dermatology Development Immunology Metabolism Neurobiology Physiology cancer
|
|
Unknown Unknown
|
MATSUI, Minoru(Graduate Sch. Pharm. Sci., Univ. Tokyo)
|
|
|
Targeted mutant.
|
B6;129-Chrm2tm1 Chrm4tm1
|
M2M4KO, C57BL/6J, 2x4
|
Chrm2 Chrm4
|
cholinergic receptor, muscarinic 2, cardiac cholinergic receptor, muscarinic 4
|
Anatomy Dermatology Development Immunology Metabolism Neurobiology Physiology cancer
|
|
Unknown Unknown
|
MATSUI, Minoru(Graduate Sch. Pharm. Sci., Univ. Tokyo)
|
|
|
Targeted mutant.
|
B6;129-Chrm2tm1 Chrm5tm1
|
2x5
|
Chrm2 Chrm5
|
cholinergic receptor, muscarinic 2, cardiac cholinergic receptor, muscarinic 5
|
Anatomy Dermatology Development Immunology Metabolism Neurobiology Physiology cancer
|
|
Unknown Unknown
|
MATSUI, Minoru
|
|
|
Targeted mutant.
|
B6;129-Chrm3tm1 Chrm4tm1
|
3x4
|
Chrm3 Chrm4
|
cholinergic receptor, muscarinic 3, cardiac cholinergic receptor, muscarinic 4
|
Anatomy Dermatology Development Immunology Metabolism Neurobiology Physiology cancer
|
|
Unknown Unknown
|
MATSUI, Minoru(Graduate Sch. Pharm. Sci., Univ. Tokyo)
|
|
|
Targeted mutant.
|
B6;129-Chrm3tm1 Chrm5tm1
|
3x5
|
Chrm3 Chrm5
|
cholinergic receptor, muscarinic 3, cardiac cholinergic receptor, muscarinic 5
|
Anatomy Dermatology Development Immunology Metabolism Neurobiology Physiology cancer
|
|
Unknown Unknown
|
MATSUI, Minoru(Graduate Sch. Pharm. Sci., Univ. Tokyo)
|
|
|
Targeted mutant.
|
B6;129-Chrm4tm1 Chrm5tm1
|
M4M5KO, C57BL/6J, 4x5
|
Chrm4 Chrm5
|
cholinergic receptor, muscarinic 4 cholinergic receptor, muscarinic 5
|
Anatomy Dermatology Development Immunology Metabolism Neurobiology Physiology cancer
|
|
Unknown Unknown
|
MATSUI, Minoru(Graduate Sch. pharm. Sci., Univ. Tokyo)
|
|
|
Targeted mutant.
|
B6;129-DSCR-1tm1ApoEtm1
|
DSCR-1, ApoE double knockout mouse
|
Apoe RCAN1
|
apolipoprotein E regulator of calcineurin 1
|
Anatomy Metabolism Physiology cancer
|
|
Minami Takashi
|
Takashi Minami(RCAST, The Univ. of Tokyo) Juda Folkman, Sandra Ryeom(Harvard Univ. Medical School)
|
|
|
Targeted mutant.
|
B6;129-DSCR-1tm1ApoEtm1
|
DSCR-1, ApoE double knockout mouse
|
Apoe RCAN1
|
apolipoprotein E regulator of calcineurin 1
|
Anatomy Metabolism Physiology cancer
|
|
Minami Takashi
|
Takashi Minami(RCAST, The Univ. of Tokyo) Juda Folkman, Sandra Ryeom(Harvard Univ. Medical School)
|
|
|
Targeted mutant.
|
B6;129-DSCR-1tm1ApoEtm1
|
DSCR-1, ApoE double knockout mouse
|
Apoe RCAN1
|
apolipoprotein E regulator of calcineurin 1
|
Anatomy Metabolism Physiology cancer
|
|
Minami Takashi
|
Takashi Minami(RCAST, The Univ. of Tokyo) Juda Folkman, Sandra Ryeom(Harvard Univ. Medical School)
|
|
|
Targeted mutant.
|
B6;129-Ddit3tm1Aki
|
Chop homo-/-
|
Ddit3
|
DNA-damage inducible transcript 3
|
Immunology Metabolism
|
|
Unknown Unknown
|
Shizuo Akira(Dept. of Host Defense Res. Inst. for Microbial Dis. Osaka Univ.)
|
|
|
Targeted mutant.
|
B6;129-Deddtm1TimyDedd2tm1Timy
|
DEDD1+/-DEDD2+/-
|
Dedd Dedd2
|
death effector domain-containing death effector domain-containing DNA binding protein 2
|
Metabolism Reproduction cancer
|
|
Miyazaki Toru
|
Toru Miyazaki(The University of Tokyo)
|
|
|
Targeted mutant.
|
B6;129-Hepacam2tm1Miya
|
A.I. KO
|
Hepacam2
|
hepatocyte cell adhesion molecule 2
|
Endocrine Disorders Metabolism
|
|
Miyazaki Jun-ichi
|
|
|
|
Targeted mutant.
|
B6;129-Mal2tm1
|
MAL2
|
Mal2
|
mal, T cell differentiation protein 2
|
Anatomy Development Metabolism Physiology
|
|
- -
|
Akihiro Harada(IMCR,Gunma University)
|
|
|
Targeted mutant.
|
B6;129-Msrtm1Csk Lox-1tm1Saw
|
B6-SR-Lox-1 WKO B6;129-Msrtm1Csk Lox-1tm1Saw
|
Macrophage scavenger receptor-1(Chr 8), Lox1 (Chr)
|
Msr, Lox1
|
Metabolism Physiology
|
|
Unknown Unknown
|
National Research Center for Protozoat Diseare Obihiro University of Agriculture and Veterinary Medicine(Hiroshi Suzuki)
|
|
|
Targeted mutant. Transgenic.
|
B6;129-Pccatm1ToruTg(SAP-Pcca)47Toru
|
PCCA KO/ PCCA TG
|
Pcca Pcca
|
propionyl-Coenzyme A carboxylase, alpha polypeptide propionyl-Coenzyme A carboxylase, alpha polypeptide
|
Metabolism
|
|
Miyazaki Toru
|
|
|
|
Targeted mutant.
|
B6;129-Ptger4tm1Sna
|
EP4KO
|
Ptger4
|
prostaglandin E receptor 4
|
Dermatology Development Immunology Metabolism Neurobiology Physiology cancer
|
|
Narumiya Shuh
|
Shu Narumiya(Kyoto University Graduate School of Medicine, Medical Innovation Center)
|
|
|
Targeted mutant.
|
B6;129-Rab8atm1 Rab8btm1
|
rab8a,rab8b double knockout mouse
|
Rab8a Rab8b
|
RAB8A, member RAS oncogene family RAB8B, member RAS oncogene family
|
Anatomy Cell biology Metabolism Neurobiology Physiology
|
|
- -
|
Akihiro Harada(I.M.C.R., Gunma Univ,)
|
|